India's preferred Personal finance destination
Home Shares News Centre F&O Mutual Funds IPO Portfolio Commodity Loans Financial Planning Insurance About Us
Markets Companies Research Industries E-Mail Page
Wealth Tracker      Tax Corner NRI Centre Chat Masala Feedback

my Last 5 Scrips
Company BSE Price(Rs) % Chg
Yes Bank 34.95 1.41
Tata Mot 150.60 4.95
State Ba 322.90 1.45
Ong Corp 98.00 4.72
Tata Stl 415.35 6.39
Clear All Clear Last
NSE Live
Nifty Live Prices
Live Quotes
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
BSE Live
BSE30 Live Prices
Live Quotes
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
Market Pulse
FII Activity
Mutual Fund Activity
Results Watch
Results Calendar
Results Announced
IPO Watch
Recent News
Broker Research
Research Tutorial
Discussion Forum
Research Reports
News Watch
Sector Watch
Economy Watch
News-Cipla Limited
Cipla Limited
Sector:Pharmaceuticals Pharmaceuticals - Bulk Drugs and Formulations
Market Lot: 1Face Value: 2ISIN Demat: INE059A01026
QuotesSnapshotChartsFinancialsResearchRecent News
Peer GroupAGM/AMMF HoldingDiscussion ForumBSE/NSE NoticesBSE/NSE Deals

Corporate News
19-Feb-2019       Cipla, Wellthy Therapeutics announce partnership to offer digital therapeutics IRIS
07-Feb-2019       Cipla gets final nod for Tadalafil tablets IRIS
28-Jan-2019       Cipla gets USFDA final approval for Medroxyprogesterone injectable IRIS
12-Nov-2018       Cipla gets USFDA final approval for Valganciclovir tablets IRIS
29-Oct-2018       Cipla receives USFDA final approval for Metoprolol ER tablets IRIS
07-Aug-2018       Cipla gets USFDA final nod for Diclofenac Sodium topical gel IRIS
19-Jun-2018       Cipla receives final approval for generic Sustiva IRIS
14-Jun-2018       Cipla gets USFDAs final approval for generic Isuprel IRIS
08-Jun-2018       Cipla, Unitaid enter into landmark deal to lower price of HIV drug IRIS
08-Jun-2018       Cipla partners with Eli Lilly & Co IRIS
22-May-2018       Cipla swings to profit in Jan-Mar quarter IRIS
02-May-2018       Cipla gets USFDA nod for generic equivalents of Vazculep, Aromasin IRIS
29-Jan-2018       Cipla receives final approval for generic Viread tablets  IRIS
01-Dec-2017       Cipla's arm enters into pact to sell 100% stake in Cipla Croatia IRIS
17-Nov-2017       Cipla receives final approval for generic Pulmicort Respules IRIS
27-Oct-2017       Cipla's arm receives final nod for generic Renvela tablets IRIS
26-Jul-2017       Cipla in partnership with MMV launches quality-assured RAS IRIS
09-Jun-2017       Cipla's arm inks pact to sell 99% stake in AJDMA IRIS
02-Jun-2017       Cipla concludes divestment of Cipla Vet, Cipla Agrimed IRIS
13-Apr-2017       Cipla's arm concludes acquisition of South Africa based Anmarate IRIS



Home | Shares | F&O | Mutual Funds | Loans | Insurance | News Centre
Wealth Tracker | Tax Corner | NRI Centre | Search in myiris | Advertise
All rights reserved. IRIS Business Services Limited